Pure Global
NCT06350149

A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis

Emory University·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Cystic Fibrosis
Drug/Device/Intervention
Sugar Sweetened Beverages (SSB)
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Emory University
Location
Atlanta, United States of America
Timeline & enrollment
Phase
N/A
Start date
Mar 22, 2024
End date
Sep 01, 2025
Enrollment
40 participants
Primary outcome

Recruitment Rate,Refusal Rate,Investigator Fidelity,Participant Fidelity,Acceptability,Retention Rates,Recruitment

Summary

The goal of this study is to determine the extent to which excess dietary simple sugars serve
 as a secondary mediating factor in Cystic fibrosis-related diabetes (CFRD) development. The
 main questions it aims to answer are:
 
 - Whether conducting a randomized 2x2 factorial design that evaluates acute postprandial
 changes in glucose over 2 hours following ingestion of a mixed meal challenge that
 varies by glycemic index and consumption of a sugar-sweetened beverage is acceptable and
 feasible.
 
 - What are the preliminary changes in postprandial hyperglycemia, islet cell function, and
 incretin response to a high or low Glycemic Index mixed meal tolerance test (MMTT) with
 and without Sugar-Sweetened Beverages (SSB) in adolescents and young adults with CF
 
 Participants will be randomized to a mixed diet and blood will be drawn before and after the
 mixed meal challenge.

ICD-10 classifications
Cystic fibrosisCystic fibrosis, unspecifiedCystic fibrosis with other manifestationsCystic fibrosis with pulmonary manifestationsCystic fibrosis with intestinal manifestations
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06350149
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06350149 through Pure Global AI's free database. This phase not specified trial is sponsored by Emory University and is currently Recruiting. The study focuses on Cystic Fibrosis. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.